P–TNM staging system for colon cancer: combination of P-stage and AJCC TNM staging system for improving prognostic prediction and clinical management

Qi Liu,1,2 Dakui Luo,1,2 Sanjun Cai,1,2 Qingguo Li,1,2 Xinxiang Li1,2 1Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China; 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republi...

Full description

Bibliographic Details
Main Authors: Liu Q, Luo D, Cai S, Li Q, Li X
Format: Article
Language:English
Published: Dove Medical Press 2018-07-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/p-tnm-staging-system-for-colon-cancer-combination-of-p-stage-and-and-a-peer-reviewed-article-CMAR
_version_ 1818152012699664384
author Liu Q
Luo D
Cai S
Li Q
Li X
author_facet Liu Q
Luo D
Cai S
Li Q
Li X
author_sort Liu Q
collection DOAJ
description Qi Liu,1,2 Dakui Luo,1,2 Sanjun Cai,1,2 Qingguo Li,1,2 Xinxiang Li1,2 1Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China; 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China Aim: This study focused on improving the American Joint Committee on Cancer TNM staging system and demonstrated an improvement in prognostic accuracy and clinical management of colon cancer using the P–TNM staging system. Patients and methods: Eligible patients (N=56,800) were identified from the Surveillance, Epidemiology, and End Results database between January 1, 2010, and December 31, 2014. The P-stage (P0 or P1) was assigned to each patient based on age at diagnosis, tumor grade, and tumor size. The outcome of interest was cancer-specific survival (CSS). The Cox proportional hazards regression analyses were used to identify independent prognostic factors and analyze the CSS probabilities of patients with colon cancer having different P–TNM stages, respectively. Results: A total of 29,627 patients were assigned to P0-stage and 27,173 patients were assigned to P1-stage. The P1-stage was associated with a 98.1% increased risk of cancer-specific mortality (hazard ratio =1.981, 95% confidence interval =1.891–2.076, P<0.001), which was higher in patients with nonmetastatic colon cancer. The P1-stage patients had improvement in CSS compared with those in P0-stage in respective stages (P<0.001). Moreover, CSS decreased in stage I–P1 compared with stage IIA–P0 or IIIA–P0 (P<0.001), stage IIIA–P1 compared with stage IIA–P0 (P<0.001), stage IIB–P1 compared with stage IIIB–P0 or IIC–P0 (P<0.001), stage IIIB–P1 compared with stage IIC–P0 (P<0.001), and stage IIC–P1 compared with stage IIIC–P0 (P<0.001). Conclusion: P-stage was an independent prognostic factor for colon cancer. This study strongly supported the incorporation of P-stage into the American Joint Committee on Cancer TNM staging system for a better approach to prognostication and, thus, more individualized risk-adaptive therapies in colon cancer. Keywords: prognostic score, colon cancer, AJCC TNM staging system
first_indexed 2024-12-11T13:47:57Z
format Article
id doaj.art-cfb8c4f0e2574b87a0871e1c3fa16bf9
institution Directory Open Access Journal
issn 1179-1322
language English
last_indexed 2024-12-11T13:47:57Z
publishDate 2018-07-01
publisher Dove Medical Press
record_format Article
series Cancer Management and Research
spelling doaj.art-cfb8c4f0e2574b87a0871e1c3fa16bf92022-12-22T01:04:24ZengDove Medical PressCancer Management and Research1179-13222018-07-01Volume 102303231439593P–TNM staging system for colon cancer: combination of P-stage and AJCC TNM staging system for improving prognostic prediction and clinical managementLiu QLuo DCai SLi QLi XQi Liu,1,2 Dakui Luo,1,2 Sanjun Cai,1,2 Qingguo Li,1,2 Xinxiang Li1,2 1Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China; 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China Aim: This study focused on improving the American Joint Committee on Cancer TNM staging system and demonstrated an improvement in prognostic accuracy and clinical management of colon cancer using the P–TNM staging system. Patients and methods: Eligible patients (N=56,800) were identified from the Surveillance, Epidemiology, and End Results database between January 1, 2010, and December 31, 2014. The P-stage (P0 or P1) was assigned to each patient based on age at diagnosis, tumor grade, and tumor size. The outcome of interest was cancer-specific survival (CSS). The Cox proportional hazards regression analyses were used to identify independent prognostic factors and analyze the CSS probabilities of patients with colon cancer having different P–TNM stages, respectively. Results: A total of 29,627 patients were assigned to P0-stage and 27,173 patients were assigned to P1-stage. The P1-stage was associated with a 98.1% increased risk of cancer-specific mortality (hazard ratio =1.981, 95% confidence interval =1.891–2.076, P<0.001), which was higher in patients with nonmetastatic colon cancer. The P1-stage patients had improvement in CSS compared with those in P0-stage in respective stages (P<0.001). Moreover, CSS decreased in stage I–P1 compared with stage IIA–P0 or IIIA–P0 (P<0.001), stage IIIA–P1 compared with stage IIA–P0 (P<0.001), stage IIB–P1 compared with stage IIIB–P0 or IIC–P0 (P<0.001), stage IIIB–P1 compared with stage IIC–P0 (P<0.001), and stage IIC–P1 compared with stage IIIC–P0 (P<0.001). Conclusion: P-stage was an independent prognostic factor for colon cancer. This study strongly supported the incorporation of P-stage into the American Joint Committee on Cancer TNM staging system for a better approach to prognostication and, thus, more individualized risk-adaptive therapies in colon cancer. Keywords: prognostic score, colon cancer, AJCC TNM staging systemhttps://www.dovepress.com/p-tnm-staging-system-for-colon-cancer-combination-of-p-stage-and-and-a-peer-reviewed-article-CMARprognostic scorecolon cancerAJCC TNM staging system
spellingShingle Liu Q
Luo D
Cai S
Li Q
Li X
P–TNM staging system for colon cancer: combination of P-stage and AJCC TNM staging system for improving prognostic prediction and clinical management
Cancer Management and Research
prognostic score
colon cancer
AJCC TNM staging system
title P–TNM staging system for colon cancer: combination of P-stage and AJCC TNM staging system for improving prognostic prediction and clinical management
title_full P–TNM staging system for colon cancer: combination of P-stage and AJCC TNM staging system for improving prognostic prediction and clinical management
title_fullStr P–TNM staging system for colon cancer: combination of P-stage and AJCC TNM staging system for improving prognostic prediction and clinical management
title_full_unstemmed P–TNM staging system for colon cancer: combination of P-stage and AJCC TNM staging system for improving prognostic prediction and clinical management
title_short P–TNM staging system for colon cancer: combination of P-stage and AJCC TNM staging system for improving prognostic prediction and clinical management
title_sort p ndash tnm staging system for colon cancer combination of p stage and ajcc tnm staging system for improving prognostic prediction and clinical management
topic prognostic score
colon cancer
AJCC TNM staging system
url https://www.dovepress.com/p-tnm-staging-system-for-colon-cancer-combination-of-p-stage-and-and-a-peer-reviewed-article-CMAR
work_keys_str_mv AT liuq pndashtnmstagingsystemforcoloncancercombinationofpstageandajcctnmstagingsystemforimprovingprognosticpredictionandclinicalmanagement
AT luod pndashtnmstagingsystemforcoloncancercombinationofpstageandajcctnmstagingsystemforimprovingprognosticpredictionandclinicalmanagement
AT cais pndashtnmstagingsystemforcoloncancercombinationofpstageandajcctnmstagingsystemforimprovingprognosticpredictionandclinicalmanagement
AT liq pndashtnmstagingsystemforcoloncancercombinationofpstageandajcctnmstagingsystemforimprovingprognosticpredictionandclinicalmanagement
AT lix pndashtnmstagingsystemforcoloncancercombinationofpstageandajcctnmstagingsystemforimprovingprognosticpredictionandclinicalmanagement